ArticleJournal of hepatology2012

Tumor progression-related transmembrane protein aspartate-β-hydroxylase is a target for immunotherapy of hepatocellular carcinoma.

Masafumi Shimoda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.